title: Caspase 9 promoter polymorphisms and risk of primary lung cancer.
abstract: Caspase-9 (CASP-9) is an initiator CASP in the apoptosome-driven apoptosis pathway and plays an important role in the development and progression of cancer. Polymorphisms in the promoter region of the CASP-9 gene may influence the promoter activity of this gene, thereby modulating susceptibility to lung cancer. To test this hypothesis, we examined the association of four polymorphisms [-1263A>G, -905T>G, -712C>T and -293_-275delCGTGAGGTCAGTGCGGGGA (-293del)] in the CASP-9 promoter with the risk of lung cancer in a Korean population. The CASP-9 genotypes were determined in 432 lung cancer patients and 432 healthy controls that were frequency-matched for age and gender. The -1263 GG genotype was associated with a significantly decreased risk of lung cancer compared with the -1263 AA genotype or combined -1263 AA+AG genotype [adjusted odds ratio (OR)=0.64, 95% confidence interval (95% CI)=0.42-0.98, P=0.04 and adjusted OR=0.67, 95% CI=0.46-0.97, P=0.01, respectively]. For the -712C>T polymorphism, individuals with at least one -712T allele were at a significantly increased risk of lung cancer compared with those harboring the -712 CC genotype (adjusted OR=1.42, 95% CI=1.06-1.89, P=0.02). Consistent with the results of genotype analyses, the -1263G/-712C (G-C) haplotype was associated with a significantly decreased risk of lung cancer [adjusted OR=0.59, 95% CI=0.47-0.75, P and Bonferroni corrected P (Pc)<0.001]. Moreover, the risk of lung cancer decreased in a dose-dependent manner as the number of the G-C haplotypes increased (adjusted OR=0.60, 95% CI=0.45-0.81, P=0.0007 and Pc=0.0014 for the G-C heterozygotes and adjusted OR=0.34, 95% CI=0.17-0.68, P=0.0023 and Pc=0.0046 for the G-C homozygotes; P(trend)<0.001). The promoter assay revealed the G-C haplotype to have a significantly higher promoter activity than the -1263G/-712T and -1263A/-712C haplotypes. These results suggest that CASP-9 promoter polymorphisms affect CASP-9 expression and contribute to genetic susceptibility to lung cancer.
authors: Cancer Research Institute, School of Medicine, Kyungpook National University, Republic of Korea. jaeyong@kyungpook.ac.kr
authors: Jae Yong
authors: JY
authors: Park
authors: Jung Min
authors: JM
authors: Park
authors: Jin Sung
authors: JS
authors: Jang
authors: Jin Eun
authors: JE
authors: Choi
authors: Kyung Mee
authors: KM
authors: Kim
authors: Sung Ick
authors: SI
authors: Cha
authors: Chang Ho
authors: CH
authors: Kim
authors: Young Mo
authors: YM
authors: Kang
authors: Won Kee
authors: WK
authors: Lee
authors: Sin
authors: S
authors: Kam
authors: Rang Woon
authors: RW
authors: Park
authors: In San
authors: IS
authors: Kim
authors: Jae-Tae
authors: JT
authors: Lee
authors: Tae Hoon
authors: TH
authors: Jung